Search clinical trials for: dasotraline 4mg

Total 12038 results

Universiteit Antwerpen
Leiden University Medical Center

Unknown

Standardization of Lead Placement for Sacral Neuromodulation Part 2

Overactive Bladder | Non Obstructive Urinary Retention

Belgium
Jonsson Comprehensive Cancer Center
NantCell, Inc.

No longer available

Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma

Ewing Sarcoma
University of Haifa

Unknown

Direction Modulation of Muscle Synergies After a Stroke

Stroke | Motor Disorders

Israel
Amgen

Completed

AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma

Asthma
Amgen

Completed

A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Amgen

Terminated

Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects

Migraine

United States
Amgen

Completed

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, United Kingdom
Amgen

Completed

Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines

Migraine

United States
Amgen

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Kyowa Kirin Co., Ltd.

Completed

Safety Study of AMG 531 in Japanese Subjects With ITP

Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Amgen

Terminated

First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia

Schizophrenia

United States
Chong Kun Dang Pharmaceutical

Completed

The Effect of Food on the Pharmacokinetic Characteristics of CKD-501 (CKD-501 FDI)

Healthy
Duke University

Completed

Breakfast Nutrition and Inpatient Glycemia

Hyperglycemia | Cardiovascular Disease | Diabetes, Type 2 | Diabetes, Type 1

United States
Lunit Inc.
King's College London; The Leeds Teaching Hospitals NHS Trust

Not yet recruiting

Real World Evaluation of Lunit INSIGHT MMG Technology

Breast Cancer | Breast Diseases

United Kingdom
Cascade Pharmaceuticals, Inc

Recruiting

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

Primary Biliary Cholangitis (PBC)

China
Cascade Pharmaceuticals, Inc

Recruiting

CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)

Primary Sclerosing Cholangitis

China
Universitair Ziekenhuis Brussel

Recruiting

Paired Assessment of Two Electromyographic Neuromuscular Monitors: Stimpod NMX450X Versus Datex-Ohmeda E-NMT

Neuromuscular Manifestations

Belgium
Amgen

Completed

Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity

Obesity

United States
Inmagene LLC

Active, not recruiting

Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants

Healthy Volunteers

Australia
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection

Influenza

China
Amgen

Terminated

Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity

Obesity

United States
Duke University

Withdrawn

Utilizing EMG Shorts in Hip Population

Hip Injuries

United States
Amgen

Completed

A Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 592 in Healthy Participants

Chronic Graft-versus-host Disease (cGVHD)

United States
Amgen

Completed

P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura

Idiopathic Thrombocytopenic Purpura
Hanmi Pharmaceutical Company Limited

Completed

Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects

Healthy Volunteer

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

Hemodialysis Patients

Korea, Republic of
Pamukkale University

Completed

Electromyographic (EMG) Biofeedback Training in Zone I-III Flexor Tendon Injuries

Flexor Tendon Rupture | Hand Therapy
Universiteit Antwerpen
Leiden University Medical Center

Unknown

Standardization of Lead Placement for Sacral Neuromodulation. Part 1

Overactive Bladder | Non Obstructive Urinary Retention

Belgium
Amgen

Completed

AMG 529 First in Human Study

Cardiovascular

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital; Amgen; H. Lee Moffitt...

Completed

AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Neuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine Tumor

United States
Amgen

Completed

Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

End Stage Renal Disease | Chronic Kidney Disease | Kidney Disease | Hyperphosphatemic
University of Southern California

Completed

Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy

Cerebral Palsy | Weakness | Hypertonia

United States
Amgen

Completed

Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With Asthma

Asthma
Purdue University
Almond Board of California

Completed

Metabolic Effects of Almond in the Longer-term Study (MEAL)

Obesity

United States
Amgen

Completed

A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women

Osteopenia
MedImmune LLC

Terminated

A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma

Moderate Asthma

United Kingdom
Seoul National University Hospital
Ministry of Trade, Industry & Energy, Republic of Korea

Not yet recruiting

Predicting Fall Risk in Stroke Patients Using a Machine Learning Model and Multi-Sensor Data

Stroke | Fall
Amgen

Recruiting

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

MTAP-null Non-Small-Cell Lung Cancer | MTAP-null Solid Tumors

United States, Australia
University Hospital, Brest
EGZOTech

Recruiting

Efficacy and Acceptability of the Luna EMG Rehabilitation Robot on Motor Recovery of the Upper Limb in the Chronic Phase of Stroke (LUNASTROKE)

Stroke

France
Ankara Yildirim Beyazıt University

Recruiting

COMPARISON OF THE LUMBAR EXTANSOR MUSCLES' ACTIVATIONS

Low Back Pain

Turkey
Amgen

Recruiting

Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity

Obesity

United States
University of Liege

Recruiting

Analysis of Shoulder Muscle Activity During Isokinetic Evaluation of Rotators

Muscle Strength | Shoulder | Electromyography | Muscle Activation

Belgium
University of Pecs

Completed

Muscle Activation in Knee Osteoarthritis

Knee Osteoarthritis

Hungary
Ankara Yildirim Beyazıt University

Completed

Selective Activation of the Infraspinatus During External Rotation Exercises in Participants With Rounded Shoulder Posture

Shoulder Disease

Turkey
Amgen

Completed

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a)

Elevated Serum Lipoprotein(a)

Hong Kong
Amgen

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Various Degrees of Hepatic Impairment

Hepatic Impairment

United States
Amgen

Terminated

Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States, Australia, Germany
Amgen

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants

Chronic Graft-versus-Host Disease (cGVHD)

Australia
Amgen

Completed

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy

Thrombocytopenia | Idiopathic Thrombocytopenic Purpura
Amgen

Completed

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

Thrombocytopenia | Idiopathic Thrombocytopenic Purpura

3

Subscribe